EP2948479
Mat og meðhöndlun á bradýkínín-miðluðum röskunum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.1.2014EP published:
1.8.2018EP application number:
14740444.6
EP translation filed:
31.10.2018Grant published:
15.11.2018EPO information:
European Patent Register
Max expiry date:
16.1.2034Expiry date:
16.1.2027Next due date:
31.1.2027
Title:
EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS
Timeline
Today
17.1.2014EP application
1.8.2018EP Publication
31.10.2018Translation submitted
15.11.2018Registration published
16.1.2027Expires
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, JP
Inventor
Name:
SEXTON, Daniel, J.Address:
Melrose, MA, US
Name:
FAUCETTE, RyanAddress:
Arlington, MA, US
Name:
KENNISTON, Jon, A.Address:
Hingham, MA, US
Name:
CONLEY, GregAddress:
Arlington, MA, US
Name:
NIXON, AndrewAddress:
Hanover, MA, US
Name:
TENHOOR, ChristopherAddress:
Hopkinton, MA, US
Name:
ADELMAN, BurtAddress:
Concord, MA, US
Name:
CHYUNG, YungAddress:
Lexington, MA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361754607 PDate:
20.1.2013Country:
US
Classification
Categories:
C07K 16/40
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 18.12.2018
Expires: 16.1.2020
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 7
Paid: 18.12.2019
Expires: 16.1.2021
Payer: Ólafur Ragnarsson hrl.
Number: 8
Paid: 17.12.2020
Expires: 16.1.2022
Payer: Patice ehf.
Number: 9
Paid: 15.12.2021
Expires: 16.1.2023
Payer: Patice ehf.
Number: 10
Paid: 22.12.2022
Expires: 16.1.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 20.12.2023
Expires: 16.1.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 27.12.2024
Expires: 16.1.2026
Payer: Árnason Faktor ehf.
Number: 13
Paid: 12.1.2026
Expires: 16.1.2027
Payer: Árnason Faktor ehf.